Detalhe da pesquisa
1.
Illuminating G-Protein-Coupling Selectivity of GPCRs.
Cell
; 177(7): 1933-1947.e25, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160049
2.
Evaluation of Medication Withdrawal in Patients with Non-systemic Juvenile Idiopathic Arthritis in Japan Using a Web-based Survey.
Mod Rheumatol
; 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441307
3.
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
Rheumatology (Oxford)
; 62(SI2): SI226-SI234, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961028
4.
Survey of diversity awareness and environment among members of the Pediatric Rheumatology Association of Japan.
Pediatr Int
; 65(1): e15654, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837236
5.
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
Rheumatology (Oxford)
; 61(3): 1222-1227, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152410
6.
Trends in actual medication use for child-onset systemic lupus erythematosus using the Japanese health insurance database 2009-18.
Mod Rheumatol
; 32(3): 565-570, 2022 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34908147
7.
Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
Rheumatology (Oxford)
; 60(4): 1839-1849, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140079
8.
Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis.
Rheumatology (Oxford)
; 60(5): 2134-2145, 2021 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067611
9.
Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.
Rheumatology (Oxford)
; 60(10): 4821-4831, 2021 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33576399
10.
External validation of the EULAR/ACR idiopathic inflammatory myopathies classification criteria with a Japanese paediatric cohort.
Rheumatology (Oxford)
; 60(2): 802-808, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810274
11.
Updated version of Japanese Childhood Health Assessment Questionnaire (CHAQ).
Mod Rheumatol
; 30(5): 905-909, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31441680
12.
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
Ann Rheum Dis
; 78(7): 988-995, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018961
13.
The 17,18-epoxyeicosatetraenoic acid-G protein-coupled receptor 40 axis ameliorates contact hypersensitivity by inhibiting neutrophil mobility in mice and cynomolgus macaques.
J Allergy Clin Immunol
; 142(2): 470-484.e12, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288079
14.
Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
Ann Rheum Dis
; 77(5): 714-719, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363513
15.
Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
Rheumatology (Oxford)
; 57(11): 1956-1963, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016492
16.
Childhood-Onset Anti-Ku Antibody-Positive Generalized Morphea with Polymyositis: A Japanese Case Study.
Pediatr Dermatol
; 32(5): e224-5, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26205636
17.
Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan.
Mod Rheumatol
; 25(1): 62-6, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25019624
18.
Clinical analysis of 50 children with juvenile dermatomyositis.
Mod Rheumatol
; 23(2): 311-7, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22526832
19.
Ectodomain shedding of EGFR ligands serves as an activation readout for TRP channels.
PLoS One
; 18(1): e0280448, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36668668
20.
Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein properties.
J Dermatol
; 49(4): 441-447, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967032